Lupin receives USFDA tentative nod for Siponimod tablets



Lupin announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Siponimod Tablets in 0.25 mg, 1 mg and 2 mg.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *